Tristar Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.20 Cr
as on 14-12-2024
- Paid Up Capital ₹ 1.20 Cr
as on 14-12-2024
- Company Age 25 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 1.26 Cr
as on 14-12-2024
- Revenue -6.90%
(FY 2022)
- Profit -326.22%
(FY 2022)
- Ebitda -52.39%
(FY 2022)
- Net Worth -6.21%
(FY 2022)
- Total Assets 119.16%
(FY 2022)
About Tristar Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.20 Cr and a paid-up capital of Rs 1.20 Cr.
The company has closed loans amounting to ₹1.26 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Harinder Aggarwal, Sumit Aggarwal, and Kamlesh Agarwal serve as directors at the Company.
- CIN/LLPIN
U24232CH1999PTC022664
- Company No.
022664
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Jun 1999
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Chandigarh, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Tristar Pharmaceuticals Private Limited offer?
Tristar Pharmaceuticals Private Limited offers a wide range of products and services, including Tour Packages, Holiday Packages, Hand Sanitizers & Personal Hygiene, Hand Sanitizer & Disinfectant.
Who are the key members and board of directors at Tristar Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sumit Aggarwal  | Managing Director | 09-Jun-1999 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Harinder Aggarwal | Director | 08-Sep-2018 | Current |
| Kamlesh Agarwal | Director | 09-Jun-1999 | Current |
Financial Performance and Corporate Structure Insights of Tristar Pharmaceuticals.
Tristar Pharmaceuticals Private Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 6.9% decrease. The company also saw a substantial fall in profitability, with a 326.22% decrease in profit. The company's net worth dipped by a decrease of 6.21%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Tristar Pharmaceuticals?
In 2021, Tristar Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
La Tech Exports Pvt LtdActive 45 years 1 monthHarinder Aggarwal, Sumit Aggarwal and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 17 Apr 2007 | ₹2.50 M | Satisfied |
Canara Bank Creation Date: 06 Oct 2004 | ₹0.37 M | Satisfied |
Canara Bank Creation Date: 10 Jan 2004 | ₹0.34 M | Satisfied |
How Many Employees Work at Tristar Pharmaceuticals?
Unlock and access historical data on people associated with Tristar Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Tristar Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Tristar Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
